We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Netrins Reverse Damage in Mouse Model of Diabetes

By Biotechdaily staff writers
Posted on 12 Jul 2006
Researchers have used a mouse model to demonstrate that netrins, proteins that help guide axon growth in the developing embryo, are capable of reversing damage caused to nervous and vascular tissues in animals with diabetes.

In the developing nervous system, axon guidance and the establishment of
appropriate neuronal connections involve a number of chemo-attractant and
chemo-repellent molecules. More...
Netrins are related to the extracellular matrix protein laminin and comprise a family of secreted molecules capable of guiding the axon growth cone.

Investigators at the University of Utah (Salt Lake City, USA) had previously shown that netrin-1 promoted blood vessel growth in cell cultures. In the current study they treated ischemic and diabetic mice with netrin-1 and compared results to those obtained with vascular endothelial growth factor (VEGF), a known stimulator of vascular growth.

Their findings, published in the June 29, 2006, online edition of Science Express, revealed that in the ischemic mice netrin-1 and VEGF promoted blood vessel growth equally well. However, in the diabetic mice, netrin-1 was a significantly more potent stimulator of blood vessel and nerve growth than VEGF.

"We now have a factor that attracts both blood vessels and nerves--that is why it is unique for diabetes,” explained senior author Dr. Dean Y. Li, assistant professor of medicine at the University of Utah. "This demonstrates that netrins are critical for development and may be important as a new therapy.”



Related Links:
University of Utah

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.